Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/108192
DC FieldValueLanguage
dc.contributor.authorPereira, Sónia G.-
dc.contributor.authorMoura, João-
dc.contributor.authorCarvalho, Eugenia-
dc.contributor.authorEmpadinhas, Nuno-
dc.date.accessioned2023-08-16T09:27:12Z-
dc.date.available2023-08-16T09:27:12Z-
dc.date.issued2017-
dc.identifier.issn1664-302Xpt
dc.identifier.urihttps://hdl.handle.net/10316/108192-
dc.description.abstractWorld Health Organization considered diabetes as one of the 20th century epidemics, estimating that over 10% of the world population is diabetic or at high risk. Self-assessment studies indicate that diabetic patients consider chronic wounds to affect their quality of life more dramatically than vision loss or renal failure. In addition to being the main reason for diabetic patients' hospitalization, the economic burden of diabetic chronic wounds is close to 1% of United Kingdom and United States health systems budgets, which exceeds the funds allocated to the treatment of some types of cancer in both countries. Among the factors preceding the emergence of chronic diabetic wounds, also designated diabetic foot ulcers (DFUs), hygiene and pressure in specific areas are under patient control, while others are still far from being understood. A triple impairment in the innervation, immune responses, and vascularization associated to DFU has been extensively studied by the scientific community. However, the skin natural microbiota has only recently emerged as having a tremendous impact on DFU emergence and evolution to chronicity. Despite the great inter- and intra-variability of microbial colonizers, ongoing efforts are now focused on deciphering the impact of commensal and pathogenic microbiota on DFU etiology, as well as the mechanisms of interkingdom microbial-host communication. This review summarizes recent work in this context and offers new microbiological perspectives that may hold potential in the prevention and treatment of chronic diabetic wounds.pt
dc.language.isoengpt
dc.publisherFrontiers Media S.A.pt
dc.relationINFARMED funding through Fundo para a Investigação em Saúde (project FIS-FIS-2015- 01_DIA_20150630-144), Fundação para a Ciência e a Tecnologia (FCT) and COMPETE 2020, Operational Programme for Competitiveness and Internationalization (POCI) project UID/NEU/04539/2013 (POCI-01-0145-FEDER-007440), The European Regional Development Fund, Centro 2020 Regional Operational Programme (CENTRO-01-0145-FEDER-000012- HealthyAging2020), EFSD European Research Programme in Microvascular Complications/Novartis Pharma AG, NIH P30AG028718 and NIH RO1AG033761.pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectmicrobiomept
dc.subjectmicrobiota and immunitypt
dc.subjectdiabetic foot ulcerspt
dc.subjectbiofilmspt
dc.subjectnovel therapeuticspt
dc.subjectinfectionpt
dc.subjectimmune responsept
dc.subjectdiabetes complicationspt
dc.titleMicrobiota of Chronic Diabetic Wounds: Ecology, Impact, and Potential for Innovative Treatment Strategiespt
dc.typearticle-
degois.publication.firstPage1791pt
degois.publication.issueSEPpt
degois.publication.titleFrontiers in Microbiologypt
dc.peerreviewedyespt
dc.identifier.doi10.3389/fmicb.2017.01791pt
degois.publication.volume8pt
dc.date.embargo2017-01-01*
uc.date.periodoEmbargo0pt
item.grantfulltextopen-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.openairetypearticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextCom Texto completo-
crisitem.author.researchunitCNC - Center for Neuroscience and Cell Biology-
crisitem.author.orcid0000-0001-6264-3632-
crisitem.author.orcid0000-0001-8938-7560-
Appears in Collections:I&D CNC - Artigos em Revistas Internacionais
Show simple item record

Page view(s)

51
checked on May 8, 2024

Download(s)

20
checked on May 8, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons